Erschienen in:
01.12.2009 | Original Article
The Vermont Diabetes Information System: A Cluster Randomized Trial of a Population Based Decision Support System
verfasst von:
Charles D. MacLean, MDCM, Michael Gagnon, MS, Peter Callas, PhD, Benjamin Littenberg, MD
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 12/2009
Einloggen, um Zugang zu erhalten
Abstract
BACKGROUND
Optimal care for patients with diabetes is difficult to achieve in clinical practice.
OBJECTIVE
To evaluate the impact of a registry and decision support system on processes of care, and physiologic control.
PARTICIPANTS
Randomized trial with clustering at the practice level, involving 7,412 adults with diabetes in 64 primary care practices in the Northeast.
INTERVENTIONS
Provider decision support (reminders for overdue diabetes tests, alerts regarding abnormal results, and quarterly population reports with peer comparisons) and patient decision support (reminders and alerts).
MEASUREMENTS AND MAIN RESULTS
Process and physiologic outcomes were evaluated in all subjects. Functional status was evaluated in a random patient sample via questionnaire. We used multiple logistic regression to quantify the effect, adjusting for clustering and potential confounders. Intervention subjects were significantly more likely to receive guideline-appropriate testing for cholesterol (OR = 1.39; [95%CI 1.07, 1.80] P = 0.012), creatinine (OR = 1.40; [95%CI 1.06, 1.84] P = 0.018), and proteinuria (OR = 1.74; [95%CI 1.13, 1.69] P = 0.012), but not A1C (OR = 1.17; [95% CI 0.80, 1.72] P = 0.43). Rates of control of A1C and LDL cholesterol were similar in the two groups. There were no differences in blood pressure, body mass index, or functional status.
CONCLUSIONS
A chronic disease registry and decision support system based on easily obtainable laboratory data was feasible and acceptable to patients and providers. This system improved the process of laboratory monitoring in primary care, but not physiologic control.